<VariationArchive VariationID="14927" VariationName="NM_000545.8(HNF1A):c.872dup (p.Gly292fs)" VariationType="Duplication" Accession="VCV000014927" Version="32" RecordType="classified" NumberOfSubmissions="16" NumberOfSubmitters="13" DateLastUpdated="2024-06-23" DateCreated="2014-05-17" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="29966" VariationID="14927">
      <GeneList>
        <Gene Symbol="HNF1A" FullName="HNF1 homeobox A" GeneID="6927" HGNC_ID="HGNC:11621" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>12q24.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="120978543" stop="121002512" display_start="120978543" display_stop="121002512" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="121416548" stop="121440314" display_start="121416548" display_stop="121440314" Strand="+" />
          </Location>
          <OMIM>142410</OMIM>
          <Haploinsufficiency last_evaluated="2023-12-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=HNF1A">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2023-12-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=HNF1A">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_000545.8(HNF1A):c.872dup (p.Gly292fs)</Name>
      <CanonicalSPDI>NC_000012.12:120994314:CCCCCCCC:CCCCCCCCC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>12q24.31</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="120994314" stop="120994315" display_start="120994314" display_stop="120994315" variantLength="1" positionVCF="120994314" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="121432117" stop="121432118" display_start="121432117" display_stop="121432118" variantLength="1" positionVCF="121432117" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
      </Location>
      <OtherNameList>
        <Name>NM_000545.6(HNF1A):c.872dup</Name>
        <Name>p.Gly292fs</Name>
      </OtherNameList>
      <ProteinChange>G292fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000545.6" sequenceAccession="NM_000545" sequenceVersion="6" change="c.872dupC">
            <Expression>NM_000545.6(HNF1A):c.872dupC</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.11" sequenceAccession="NC_000012" sequenceVersion="11" change="g.121432125dup" Assembly="GRCh37">
            <Expression>NC_000012.11:g.121432125dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.12" sequenceAccession="NC_000012" sequenceVersion="12" change="g.120994322dup" Assembly="GRCh38">
            <Expression>NC_000012.12:g.120994322dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011731.2" sequenceAccession="NG_011731" sequenceVersion="2" change="g.20577dup">
            <Expression>NG_011731.2:g.20577dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000545.8" sequenceAccession="NM_000545" sequenceVersion="8" change="c.872dup" MANESelect="true">
            <Expression>NM_000545.8:c.872dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000536.6" sequenceAccession="NP_000536" sequenceVersion="6" change="p.Gly292fs">
            <Expression>NP_000536.6:p.Gly292fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001306179.2" sequenceAccession="NM_001306179" sequenceVersion="2" change="c.872dup">
            <Expression>NM_001306179.2:c.872dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001293108.2" sequenceAccession="NP_001293108" sequenceVersion="2" change="p.Gly292fs">
            <Expression>NP_001293108.2:p.Gly292fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_522" sequenceAccession="LRG_522">
            <Expression>LRG_522:g.20577dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_522t1" sequenceAccession="LRG_522t1">
            <Expression>LRG_522t1:c.872dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000545.6" sequenceAccession="NM_000545" sequenceVersion="6" change="c.872dupC">
            <Expression>NM_000545.6:c.872dupC</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="587776825" DB="dbSNP" />
        <XRef ID="CA124453" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="142410.0001" DB="OMIM" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000545.8(HNF1A):c.872dup (p.Gly292fs) AND Maturity-onset diabetes of the young type 3" Accession="RCV000016062" Version="33">
        <ClassifiedConditionList TraitSetID="4146">
          <ClassifiedCondition DB="MedGen" ID="C1838100">Maturity-onset diabetes of the young type 3</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-02-02" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000545.8(HNF1A):c.872dup (p.Gly292fs) AND Clear cell carcinoma of kidney" Accession="RCV000016063" Version="27">
        <ClassifiedConditionList TraitSetID="11856">
          <ClassifiedCondition DB="MedGen" ID="C0279702">Clear cell carcinoma of kidney</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2005-03-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000545.8(HNF1A):c.872dup (p.Gly292fs) AND Hepatic adenomas, familial" Accession="RCV000022617" Version="9">
        <ClassifiedConditionList TraitSetID="6348">
          <ClassifiedCondition DB="MedGen" ID="C1840646">Hepatic adenomas, familial</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2005-03-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000545.8(HNF1A):c.872dup (p.Gly292fs) AND Diabetes mellitus type 1" Accession="RCV000117225" Version="8">
        <ClassifiedConditionList TraitSetID="6440">
          <ClassifiedCondition DB="MedGen" ID="C0011854">Diabetes mellitus type 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2022-01-11" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000545.8(HNF1A):c.872dup (p.Gly292fs) AND not provided" Accession="RCV000490055" Version="15">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-10-17" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000545.8(HNF1A):c.872dup (p.Gly292fs) AND Type 1 diabetes mellitus 20" Accession="RCV001255183" Version="2">
        <ClassifiedConditionList TraitSetID="4149">
          <ClassifiedCondition DB="MedGen" ID="C2675866">Type 1 diabetes mellitus 20</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2005-03-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000545.8(HNF1A):c.872dup (p.Gly292fs) AND Monogenic diabetes" Accession="RCV002221997" Version="3">
        <ClassifiedConditionList TraitSetID="35375">
          <ClassifiedCondition DB="MedGen" ID="C3888631">Monogenic diabetes</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>reviewed by expert panel</ReviewStatus>
            <Description DateLastEvaluated="2022-04-15" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000545.8(HNF1A):c.872dup (p.Gly292fs) AND Maturity onset diabetes mellitus in young" Accession="RCV001506982" Version="9">
        <ClassifiedConditionList TraitSetID="9499">
          <ClassifiedCondition DB="MedGen" ID="C0342276">Maturity onset diabetes mellitus in young</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-09-26" SubmissionCount="4">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000545.8(HNF1A):c.872dup (p.Gly292fs) AND DiGeorge syndrome" Accession="RCV003445070" Version="1">
        <ClassifiedConditionList TraitSetID="2059">
          <ClassifiedCondition DB="MedGen" ID="C0012236">DiGeorge syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-04-15" NumberOfSubmissions="16" NumberOfSubmitters="13" DateCreated="2014-05-17" MostRecentSubmission="2024-05-01">
        <ReviewStatus>reviewed by expert panel</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">14747304</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15649945</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15928245</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17054605</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17407387</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17440016</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17573900</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17937063</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17989309</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18003757</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18672310</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21051477</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21628466</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23348805</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23551881</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23607861</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25174781</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25555642</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28862987</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29417725</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30814848</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32741144</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">34373539</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8866553</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8945470</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9032114</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9045858</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9075818</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9166684</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9313763</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9439666</ID>
        </Citation>
        <Citation Type="general">
          <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/66aac3c5-4bd9-4fa1-b60a-bd6b1f1f1b17</URL>
        </Citation>
        <Citation Type="general">
          <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/cde6fb52-5469-4017-b30d-60b5d552ef1f</URL>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">10333057</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">10447526</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">10754480</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">11058894</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">11315851</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12050210</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12355088</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12530534</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12574234</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12618559</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="11856" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="18267" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Clear-cell metastatic renal cell carcinoma (subtype)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Clear cell renal cell carcinoma</ElementValue>
                <XRef ID="HP:0006770" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Clear cell RCC</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cystic-multilocular variant</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Renal cell carcinoma, clear cell, somatic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Clear cell renal carcinoma</ElementValue>
                <XRef ID="MONDO:0005005" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Clear cell carcinoma of kidney</ElementValue>
                <XRef ID="254915003" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9574" />
                <XRef ID="9574" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="319276" DB="Orphanet" />
              <XRef ID="C0279702" DB="MedGen" />
              <XRef ID="MONDO:0005005" DB="MONDO" />
              <XRef Type="primary" ID="HP:0006770" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6440" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="1089" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Type I diabetes mellitus</ElementValue>
                <XRef ID="HP:0100651" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Diabetes mellitus type 1</ElementValue>
                <XRef ID="Diabetes+mellitus+type+1/8214" DB="Genetic Alliance" />
                <XRef ID="46635009" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">T1D</ElementValue>
                <XRef Type="MIM" ID="222100" DB="OMIM" />
              </Symbol>
              <Citation Type="practice guideline" Abbrev="NICE, 2023">
                <URL>https://www.nice.org.uk/guidance/cg181</URL>
                <CitationText>UK NICE Guidance, Clinical Guideline CG181, Cardiovascular disease: risk assessment and reduction, including lipid modification, 2023</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2022">
                <URL>https://www.nice.org.uk/guidance/ng17</URL>
                <CitationText>UK NICE Guideline NG17, Type 1 diabetes in adults: diagnosis and management, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2023">
                <URL>https://www.nice.org.uk/guidance/ng18</URL>
                <CitationText>UK NICE Guideline NG18, Diabetes (type 1 and type 2) in children and young people: diagnosis and management, 2023</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2020">
                <URL>https://www.nice.org.uk/guidance/ng3</URL>
                <CitationText>UK NICE Guideline NG3, Diabetes in pregnancy: management from preconception to the postnatal period</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2019">
                <URL>https://www.nice.org.uk/guidance/ng19</URL>
                <CitationText>UK NICE Guideline NG19, Diabetic foot problems: prevention and management, 2019</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2023">
                <URL>https://www.nice.org.uk/guidance/ng238</URL>
                <CitationText>UK NICE Guideline NG238, Cardiovascular disease: risk assessment and reduction, including lipid modification, 2023</CitationText>
              </Citation>
              <XRef ID="C0011854" DB="MedGen" />
              <XRef ID="MONDO:0005147" DB="MONDO" />
              <XRef Type="MIM" ID="222100" DB="OMIM" />
              <XRef Type="primary" ID="HP:0100651" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6348" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="5242" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">LIVER CELL ADENOMAS, FAMILIAL</ElementValue>
                <XRef Type="MIM" ID="142330" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HEPATIC ADENOMA, SOMATIC</ElementValue>
                <XRef Type="Allelic variant" ID="142410.0001" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hepatic adenomas, familial</ElementValue>
                <XRef ID="Hepatic+adenomas%2C+familial/8507" DB="Genetic Alliance" />
                <XRef ID="MONDO:0007718" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <XRef ID="C1840646" DB="MedGen" />
              <XRef ID="MONDO:0007718" DB="MONDO" />
              <XRef Type="MIM" ID="142330" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="4146" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="2650" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Maturity-onset diabetes of the young type 3</ElementValue>
                <XRef ID="MONDO:0010894" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MODY  type 3</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">MODY, type III</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Diabetes mellitus MODY type 3</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">MODY hepatocyte nuclear factor-1-alpha related</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MODY3</ElementValue>
                <XRef Type="MIM" ID="600496" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000552549" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522248" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570044" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558434" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552546" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000509011" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556820" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000512817" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000557910" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000327171" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000559250" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552325" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000512295" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000595971" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552542" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10658" />
                <XRef ID="10658" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29792621</ID>
                <ID Source="BookShelf">NBK500456</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <XRef ID="552" DB="Orphanet" />
              <XRef ID="C1838100" DB="MedGen" />
              <XRef ID="MONDO:0010894" DB="MONDO" />
              <XRef Type="MIM" ID="600496" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="35375" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="37052" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Monogenic diabetes</ElementValue>
                <XRef ID="MONDO:0015967" DB="MONDO" />
                <XRef ID="PDMP0008" DB="Personalized Diabetes Medicine Program, University of Maryland School of Medicine" />
              </Name>
              <XRef ID="183625" DB="Orphanet" />
              <XRef ID="C3888631" DB="MedGen" />
              <XRef ID="MONDO:0015967" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9499" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="5457" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Maturity onset diabetes mellitus in young</ElementValue>
                <XRef ID="28453007" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mason type diabetes</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MODY</ElementValue>
                <XRef ID="HP:0004904" DB="Human Phenotype Ontology" />
                <XRef Type="MIM" ID="606391" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3697" />
                <XRef ID="3697" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29792621</ID>
                <ID Source="BookShelf">NBK500456</ID>
              </Citation>
              <XRef ID="552" DB="Orphanet" />
              <XRef ID="C0342276" DB="MedGen" />
              <XRef ID="MONDO:0018911" DB="MONDO" />
              <XRef Type="MIM" ID="606391" DB="OMIM" />
              <XRef Type="primary" ID="HP:0004904" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="4149" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="1476" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Type 1 diabetes mellitus 20</ElementValue>
                <XRef ID="MONDO:0012919" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Diabetes mellitus, insulin-dependent, 20</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">T1D20</ElementValue>
                <XRef Type="MIM" ID="612520" DB="OMIM" />
              </Symbol>
              <XRef ID="C2675866" DB="MedGen" />
              <XRef ID="MONDO:0012919" DB="MONDO" />
              <XRef Type="MIM" ID="612520" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="2059" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="4960" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">DiGeorge syndrome</ElementValue>
                <XRef ID="MONDO:0008564" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Catch22</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hypoplasia of thymus and parathyroid</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Third and fourth pharyngeal pouch syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">DiGeorge anomaly</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">DiGeorge sequence</ElementValue>
                <XRef ID="22q11.2+Deletion+Syndrome/20" DB="Genetic Alliance" />
                <XRef ID="Sedlackova+syndrome/6482" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial third and fourth pharyngeal pouch syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Pharyngeal pouch syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Thymic aplasia syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">DGS</ElementValue>
                <XRef Type="MIM" ID="188400" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Individuals with 22q11.2 deletion syndrome (22q11.2DS) can present with a wide range of features that are highly variable, even within families. The major clinical manifestations of 22q11.2DS include congenital heart disease, particularly conotruncal malformations (ventricular septal defect, tetralogy of Fallot, interrupted aortic arch, and truncus arteriosus), palatal abnormalities (velopharyngeal incompetence, submucosal cleft palate, bifid uvula, and cleft palate), immune deficiency, characteristic facial features, and learning difficulties. Hearing loss can be sensorineural and/or conductive. Laryngotracheoesophageal, gastrointestinal, ophthalmologic, central nervous system, skeletal, and genitourinary anomalies also occur. Psychiatric illness and autoimmune disorders are more common in individuals with 22q11.2DS.</Attribute>
                <XRef ID="NBK1523" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15118" />
                <XRef ID="15118" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301696</ID>
                <ID Source="BookShelf">NBK1523</ID>
              </Citation>
              <Citation Type="general" Abbrev="Int'l 22q11.2 Del Syndrome Consortium, 2011">
                <ID Source="pmc">3197829</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2010">
                <ID Source="pmc">2987430</ID>
              </Citation>
              <Citation Type="general">
                <ID Source="PubMed">11195019</ID>
              </Citation>
              <Citation Type="general" Abbrev="Fung et. al., 2015">
                <ID Source="PubMed">25569435</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27467454</ID>
              </Citation>
              <XRef ID="567" DB="Orphanet" />
              <XRef ID="C0012236" DB="MedGen" />
              <XRef ID="MONDO:0008564" DB="MONDO" />
              <XRef Type="MIM" ID="188400" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2804983" SubmissionDate="2020-03-09" DateLastUpdated="2022-02-01" DateCreated="2020-07-19">
        <ClinVarSubmissionID localKey="66aac3c5-4bd9-4fa1-b60a-bd6b1f1f1b17|OMIM:600496" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001422572" DateUpdated="2022-02-01" DateCreated="2020-07-19" Type="SCV" Version="2" SubmitterName="Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard" OrgID="506627" OrganizationCategory="laboratory" OrgAbbreviation="Broad RDG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-01-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">17573900</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25174781</ID>
          </Citation>
          <Citation>
            <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/66aac3c5-4bd9-4fa1-b60a-bd6b1f1f1b17</URL>
          </Citation>
          <Comment>The p.Gly292Argfs25 variant in HNF1A has been reported in 7 individuals with maturity-onset diabetes of the young, segregated with disease in 6 affected relatives from 3 families (PMID: 25174781, 17573900) and has also been reported pathogenic by 4 unique submitters in ClinVar (Variation ID: 14927). Data from large population studies is insufficient to assess the frequency of this variant. The number of reported affected individuals with this variant is slightly greater than expected compared to non-affected individuals with this variant. This variant is predicted to cause a frameshift, which alters the protein's amino acid sequence beginning at position 292 and leads to a premature termination codon 25 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Heterozygous loss of function of the HNF1A gene is an established disease mechanism in maturity-onset diabetes of the young. In summary, this variant meets criteria to be classified as pathogenic for maturity-onset diabetes of the young in an autosomal dominant manner based on the predicted impact of the variant and segregation with disease in multiple families. ACMG/AMP Criteria applied: PVS1, PP1_Moderate, PS4_Supporting (Richards 2015).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation Abbrev="ACMG, 2015" Type="practice guideline">
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HNF1A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_000545.6(HNF1A):c.872dupC</Name>
            <Name>p.Gly292Argfs</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000012.12:g.120994322dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="600496" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6906750</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion FDARecognizedDatabase="true" ID="4889842" SubmissionDate="2022-04-15" DateLastUpdated="2022-04-23" DateCreated="2022-04-23">
        <ClinVarSubmissionID localKey="cde6fb52-5469-4017-b30d-60b5d552ef1f" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002499554" DateUpdated="2022-04-23" DateCreated="2022-04-23" Type="SCV" Version="1" SubmitterName="ClinGen Monogenic Diabetes Variant Curation Expert Panel" OrgID="508240" OrganizationCategory="consortium" OrgAbbreviation="Diabetes VCEP" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-04-15">
          <ReviewStatus>reviewed by expert panel</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/cde6fb52-5469-4017-b30d-60b5d552ef1f</URL>
          </Citation>
          <Comment>The c.872dupC variant in the HNF1 homeobox A gene, HNF1A, causes a frameshift in the protein at codon 292 (NM_000545.8), adding 25 novel amino acids before encountering a stop codon (p.(Gly292ArgfsTer25)). This variant, located in biologically-relevant exon 4 of 10, is predicted to lead to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1; PMID: 23348805). Additionally, this variant segregated with diabetes, with at least 100 informative meioses in multiple families with MODY (PP1_Strong; internal lab contributors). This variant was identified as a de novo occurrence with confirmed parental relationships in one individual and unconfirmed parental relationships in another individual with diabetes, but whose clinical picture is suggestive but not highly specific for HNF1A-MODY (MODY probability calculator result &gt;50% but HNF4A not tested) (PS2_Moderate; PMID:9166684, internal lab contributors). The variant is located in a poly-C tract and failed QC in gnomAD v2.1.1 in a manner typical of single base deletions in poly-C tracts in NGS; therefore, PM2_Supporting could not be applied. This variant was identified in at least 200 unrelated individuals with non- autoimmune and non-absolute/near-absolute insulin-deficient diabetes; however, PS4_Moderate cannot be applied because PM2_Supporting cannot be applied (internal lab contributors). In summary, c.872dupC meets the criteria to be classified as pathogenic for monogenic diabetes. ACMG/AMP criteria applied, as specified by the ClinGen MDEP (specification version 1.1, approved 9/30/21): PVS1, PS2_Moderate, PP1_Strong.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ClinGen Diabetes ACMG Specifications v1 1</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/2gqvx1fn/clingen_diabetes_acmg_specifications_v1_1.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HNF1A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_000545.6(HNF1A):c.872dup</Name>
            <Name>p.Gly292fs</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000012.12:g.120994322dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0015967" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11340261</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5399180" SubmissionDate="2022-11-22" DateLastUpdated="2022-12-11" DateCreated="2022-12-11">
        <ClinVarSubmissionID localKey="SUB12315107" submittedAssembly="GRCh38" title="SUB12315107" />
        <ClinVarAccession Accession="SCV002605529" DateUpdated="2022-12-11" DateCreated="2022-12-11" Type="SCV" Version="1" SubmitterName="Clinical Genomics, Uppaluri K&amp;H Personalized Medicine Clinic" OrgID="508223" OrganizationCategory="clinic" OrgAbbreviation="K&amp;H CLINIC" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">32741144</ID>
          </Citation>
          <Comment>Mutations in HNF1A gene can predispose to MODY3. It is associated with both micro and macrovascular complications of diabetes, especially cardiovascular complications. Associated with glucosuria. May respond well to sulfonylureas. Sufficient evidence is found to confer the association of this particular variant rs587776825 with MODY3.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">K &amp; H Uppaluri Personalized Medicine Clinic Variant Classification &amp; Assertion Criteria_Updated V.1</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/var90ofb/k_h_uppaluri_personalized_medicine_clinic_variant_classification_assertion_criteria_updated_1_.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HNF1A">
              <Name>HNF1 homeobox A</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <XRefList>
            <XRef DB="dbSNP" ID="rs587776825" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000012.12:g.120994322dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="HP" ID="HP:0004904" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12315107</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1122906" SubmissionDate="2022-03-23" DateLastUpdated="2023-03-04" DateCreated="2017-05-22">
        <ClinVarSubmissionID localKey="GDXSV:223222" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000576668" DateUpdated="2023-03-04" DateCreated="2017-05-22" Type="SCV" Version="7" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" OrgAbbreviation="GDX" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 25174781, 21628466, 23551881, 29417725, 28170077, 12530534, 23607861, 8945470, 21051477, 27153395, 28012402, 29666556, 27913849, 29493090, 29927023, 28862987, 30814848, 30641602, 11058894, 12574234, 31291970, 32041611, 33031055)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HNF1A" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:26168</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000545.5:c.872dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_58_20211001044204</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_96_20220323054204</SubmissionName>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7677315" SubmissionDate="2023-10-27" DateLastUpdated="2023-11-04" DateCreated="2023-11-04">
        <ClinVarSubmissionID localKey="NM_000545.6:c.872dupC|MedGen:C0342276" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004100139" DateUpdated="2023-11-04" DateCreated="2023-11-04" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-09-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12050210</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9166684</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9313763</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">8945470</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17989309</ID>
          </Citation>
          <Comment>Variant summary: HNF1A c.872dupC (p.Gly292ArgfsX25) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 0.00037 in 228182 control chromosomes (gnomAD), however the variant failed random forest filters and therefore the available allele frequency data may not be reliable. c.872dupC has been reported in the literature in multiple individuals affected with Maturity Onset Diabetes Of The Young 3 (e.g., Vesterhus_2008, Yamagata_1996, Yamada_1997, Glucksmann_1997, Barrio_2002). These data indicate that the variant is very likely to be associated with disease. The following publications have been ascertained in the context of this evaluation (PMID: 12050210, 9166684, 9313763, 8945470, 17989309). Eight submitters, including the ClinGen Monogenic Diabetes Variant Curation Expert Panel, have reported clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HNF1A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000545.6:c.872dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0342276" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13932418</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7809795" SubmissionDate="2023-10-31" DateLastUpdated="2023-12-09" DateCreated="2023-12-09">
        <ClinVarSubmissionID localKey="NM_000545.5:c.872dupC|OMIM:188400" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004174116" DateUpdated="2023-12-09" DateCreated="2023-12-09" Type="SCV" Version="1" SubmitterName="Seattle Children's Hospital Molecular Genetics Laboratory, Seattle Children's Hospital" OrgID="506512" OrganizationCategory="laboratory" OrgAbbreviation="SCH MGL" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HNF1A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000545.5:c.872dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="188400" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13939377</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1197291" SubmissionDate="2024-01-03" DateLastUpdated="2024-01-26" DateCreated="2017-05-22">
        <ClinVarSubmissionID localKey="A379|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000613637" DateUpdated="2024-01-26" DateCreated="2017-05-22" Type="SCV" Version="6" SubmitterName="Athena Diagnostics" OrgID="1012" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-02-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12530534</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21628466</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23607861</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23551881</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21051477</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25174781</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28862987</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29417725</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30814848</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10333057</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10447526</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10754480</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11315851</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12050210</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12574234</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12618559</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15928245</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17054605</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17407387</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17440016</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17573900</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17937063</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17989309</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18672310</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">8945470</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9032114</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9045858</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9075818</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9166684</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9313763</ID>
          </Citation>
          <Comment>This variant is expected to result in the loss of a functional protein. The frequency data have failed quality metrics and thus are not useful in evaluating the pathogenicity of this variant (Genome Aggregation Database (gnomAD), Cambridge, MA (URL: http://gnomad.broadinstitute.org)). This variant segregates with disease in multiple families. Assessment of experimental evidence suggests this variant results in abnormal protein function. An in vitro study showed the mRNA transcript is 30% less stable than wild-type, likely due to nonsense mediated decay (PMID: 12530534).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Athena Diagnostics Criteria</Attribute>
          <Citation>
            <ID Source="PubMed">26467025</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000545.5:c.872dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10229685</SubmissionName>
          <SubmissionName>SUB12478070</SubmissionName>
          <SubmissionName>SUB14108777</SubmissionName>
          <SubmissionName>SUB8819545</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="6159173" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="627498|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003470424" DateUpdated="2024-02-20" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15928245</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18003757</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">8945470</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28862987</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Gly292Argfs*25) in the HNF1A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in HNF1A are known to be pathogenic (PMID: 15928245, 18003757). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individual(s) with autosomal dominant maturity-onset diabetes of the young 3 (MODY3) (PMID: 8945470, 28862987). It has also been observed to segregate with disease in related individuals. This variant is also known as P291fsinsC. ClinVar contains an entry for this variant (Variation ID: 14927). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HNF1A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000012.11:g.121432117_121432118insC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9056166" SubmissionDate="2024-04-19" DateLastUpdated="2024-04-20" DateCreated="2024-04-20">
        <ClinVarSubmissionID localKey="101865323|Orphanet:ORPHA552" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV004848484" DateUpdated="2024-04-20" DateCreated="2024-04-20" Type="SCV" Version="1" SubmitterName="Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine" OrgID="21766" OrganizationCategory="laboratory" OrgAbbreviation="LMM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-01-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23348805</ID>
          </Citation>
          <Comment>The p.Gly292ArgfsX25 variant in HNF1A is the most frequently reported HNF1A variant and has been reported (initially as p.P291fsinsC) in more than 100 individuals with maturity-onset diabetes of the young (MODY; Colclough 2013 PMID: 23348805) and segregated with disease in at least 100 affected family members. It was also classified as pathogenic on April 23, 2022 by the ClinGen-approved Monogenic Diabetes expert panel (Variation ID 14927). Data from large population studies is insufficient to assess the frequency of this variant. This variant is predicted to cause a frameshift, which alters the protein’s amino acid sequence beginning at position 292 and leads to a premature termination codon 25 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Heterozygous loss of function of the HNF1A gene is an established disease mechanism in autosomal dominant monogenic diabetes. In summary, this variant meets criteria to be classified as pathogenic for autosomal dominant MODY. ACMG/AMP Criteria applied: PVS1, PS4, PP1_Strong.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HNF1A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_000545.8:exon 4</GeneLocation>
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000012.12:g.120994322_120994323insC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="ORPHA552" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14389831</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="36331" SubmissionDate="2020-09-04" DateLastUpdated="2020-09-14" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="142410.0001_RENAL CELL CARCINOMA, CLEAR CELL" title="HNF1A, 1-BP INS, 872C_RENAL CELL CARCINOMA, CLEAR CELL" />
        <ClinVarAccession Accession="SCV000036331" DateUpdated="2020-09-14" DateCreated="2013-04-04" Type="SCV" Version="5" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2005-03-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to included disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Maturity-Onset Diabetes of the Young, Type 3</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a patient from an Edinburgh pedigree with MODY3 (600496), Yamagata et al. (1996) found in exon 4 of the TCF1 gene an insertion of a cytosine at codon 291 (pro), resulting in a frameshift and synthesis of a truncated mutant protein of 315 amino acids. This mutation was present in all affected members and no unaffected members of this family. It was not found on screening 55 healthy nondiabetic white subjects.</Attribute>
              <Citation>
                <ID Source="PubMed">8945470</ID>
              </Citation>
              <XRef DB="OMIM" ID="600496" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Using a rapid screening PCR method for frameshift mutations in the HNF1A gene in the screening of 60 MODY probands defined according to strict diagnostic criteria, Frayling et al. (1997) detected mutations in 11 (18%); the insertion mutation accounted for 13% of the MODY cases.</Attribute>
              <Citation>
                <ID Source="PubMed">9439666</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Ellard (2000) stated that the C insertion in the poly(C) tract of exon 4 had been reported in 22 of the 116 families with MODY3 worldwide who were identified by the finding of a mutation in the TCF1 gene. The total number of different mutations described was 65.</Attribute>
              <Citation>
                <ID Source="PubMed">11058894</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Bjorkhaug et al. (2003) found the P291fsinsC mutation in 9 families, 8 of Norwegian origin. Microsatellite analysis data suggested that in 7 of these families the mutant allele had a common origin.</Attribute>
              <Citation>
                <ID Source="PubMed">12574234</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Hepatic Adenoma</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In studies of hepatic adenomas (142330) demonstrating biallelic inactivation of TCF1, Bluteau et al. (2002) observed the pro291fsX316 frameshift mutation (142410.0001) in heterozygous state in the tumor tissue of 2 individuals, one with multiple adenoma and the other with hepatocellular carcinoma (114550).</Attribute>
              <Citation>
                <ID Source="PubMed">12355088</ID>
              </Citation>
              <XRef DB="OMIM" ID="142330" Type="MIM" />
              <XRef DB="OMIM" ID="114550" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Renal Cell Carcinoma</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a 78-year-old man with clear cell renal carcinoma (see 144700), Rebouissou et al. (2005) identified heterozygosity for the 872insC mutation. Mutation screening of a tumor sample detected the germline mutation without mutation/deletion of the second allele. The man was diagnosed with diabetes mellitus in his sixth decade that was controlled by diet and oral hypoglycemic agents. No relatives had a diagnosis of renal carcinoma or diabetes.</Attribute>
              <Citation>
                <ID Source="PubMed">15649945</ID>
              </Citation>
              <XRef DB="OMIM" ID="144700" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Type 1 Diabetes Mellitus 20</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a Japanese subject with type 1 diabetes mellitus (T1D20; 612520) in whom insulin treatment was begun when hyperglycemia and ketonuria were noticed at 15 years of age, Yamada et al. (1997) identified a heterozygous frameshift mutation of codon pro291 resulting from insertion of a C in a poly(C) tract. (They designated this mutation P291fsinsC.) The mutation was predicted to result in a mutant truncated protein of 340 amino acids. The same mutation had been observed in British, German, and Finnish MODY families (Byrne et al., 1996; Yamagata et al., 1996; Kaisaki et al., 1997). Thus, Yamada et al. (1997) concluded that this site in exon 4 of the HNF1A gene appears to be a mutation hotspot.</Attribute>
              <Citation>
                <ID Source="PubMed">9313763</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">8866553</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">8945470</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">9032114</ID>
              </Citation>
              <XRef DB="OMIM" ID="612520" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HNF1A" />
          </GeneList>
          <Name>HNF1A, 1-BP INS, 872C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 872C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="142410.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="included">RENAL CELL CARCINOMA, CLEAR CELL</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2827227" SubmissionDate="2020-09-04" DateLastUpdated="2020-09-14" DateCreated="2020-09-14">
        <ClinVarSubmissionID localKey="142410.0001_TYPE 1 DIABETES MELLITUS 20" title="HNF1A, 1-BP INS, 872C_TYPE 1 DIABETES MELLITUS 20" />
        <ClinVarAccession Accession="SCV001431537" DateUpdated="2020-09-14" DateCreated="2020-09-14" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2005-03-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to included disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Maturity-Onset Diabetes of the Young, Type 3</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a patient from an Edinburgh pedigree with MODY3 (600496), Yamagata et al. (1996) found in exon 4 of the TCF1 gene an insertion of a cytosine at codon 291 (pro), resulting in a frameshift and synthesis of a truncated mutant protein of 315 amino acids. This mutation was present in all affected members and no unaffected members of this family. It was not found on screening 55 healthy nondiabetic white subjects.</Attribute>
              <Citation>
                <ID Source="PubMed">8945470</ID>
              </Citation>
              <XRef DB="OMIM" ID="600496" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Using a rapid screening PCR method for frameshift mutations in the HNF1A gene in the screening of 60 MODY probands defined according to strict diagnostic criteria, Frayling et al. (1997) detected mutations in 11 (18%); the insertion mutation accounted for 13% of the MODY cases.</Attribute>
              <Citation>
                <ID Source="PubMed">9439666</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Ellard (2000) stated that the C insertion in the poly(C) tract of exon 4 had been reported in 22 of the 116 families with MODY3 worldwide who were identified by the finding of a mutation in the TCF1 gene. The total number of different mutations described was 65.</Attribute>
              <Citation>
                <ID Source="PubMed">11058894</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Bjorkhaug et al. (2003) found the P291fsinsC mutation in 9 families, 8 of Norwegian origin. Microsatellite analysis data suggested that in 7 of these families the mutant allele had a common origin.</Attribute>
              <Citation>
                <ID Source="PubMed">12574234</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Hepatic Adenoma</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In studies of hepatic adenomas (142330) demonstrating biallelic inactivation of TCF1, Bluteau et al. (2002) observed the pro291fsX316 frameshift mutation (142410.0001) in heterozygous state in the tumor tissue of 2 individuals, one with multiple adenoma and the other with hepatocellular carcinoma (114550).</Attribute>
              <Citation>
                <ID Source="PubMed">12355088</ID>
              </Citation>
              <XRef DB="OMIM" ID="142330" Type="MIM" />
              <XRef DB="OMIM" ID="114550" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Renal Cell Carcinoma</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a 78-year-old man with clear cell renal carcinoma (see 144700), Rebouissou et al. (2005) identified heterozygosity for the 872insC mutation. Mutation screening of a tumor sample detected the germline mutation without mutation/deletion of the second allele. The man was diagnosed with diabetes mellitus in his sixth decade that was controlled by diet and oral hypoglycemic agents. No relatives had a diagnosis of renal carcinoma or diabetes.</Attribute>
              <Citation>
                <ID Source="PubMed">15649945</ID>
              </Citation>
              <XRef DB="OMIM" ID="144700" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Type 1 Diabetes Mellitus 20</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a Japanese subject with type 1 diabetes mellitus (T1D20; 612520) in whom insulin treatment was begun when hyperglycemia and ketonuria were noticed at 15 years of age, Yamada et al. (1997) identified a heterozygous frameshift mutation of codon pro291 resulting from insertion of a C in a poly(C) tract. (They designated this mutation P291fsinsC.) The mutation was predicted to result in a mutant truncated protein of 340 amino acids. The same mutation had been observed in British, German, and Finnish MODY families (Byrne et al., 1996; Yamagata et al., 1996; Kaisaki et al., 1997). Thus, Yamada et al. (1997) concluded that this site in exon 4 of the HNF1A gene appears to be a mutation hotspot.</Attribute>
              <Citation>
                <ID Source="PubMed">9313763</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">8866553</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">8945470</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">9032114</ID>
              </Citation>
              <XRef DB="OMIM" ID="612520" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HNF1A" />
          </GeneList>
          <Name>HNF1A, 1-BP INS, 872C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 872C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="142410.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="included">TYPE 1 DIABETES MELLITUS 20</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="49162" SubmissionDate="2020-09-04" DateLastUpdated="2020-09-14" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="142410.0001_HEPATIC ADENOMA, SOMATIC" title="HNF1A, 1-BP INS, 872C_HEPATIC ADENOMA, SOMATIC" />
        <ClinVarAccession Accession="SCV000043906" DateUpdated="2020-09-14" DateCreated="2013-04-04" Type="SCV" Version="5" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2005-03-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to included disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>somatic</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Maturity-Onset Diabetes of the Young, Type 3</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a patient from an Edinburgh pedigree with MODY3 (600496), Yamagata et al. (1996) found in exon 4 of the TCF1 gene an insertion of a cytosine at codon 291 (pro), resulting in a frameshift and synthesis of a truncated mutant protein of 315 amino acids. This mutation was present in all affected members and no unaffected members of this family. It was not found on screening 55 healthy nondiabetic white subjects.</Attribute>
              <Citation>
                <ID Source="PubMed">8945470</ID>
              </Citation>
              <XRef DB="OMIM" ID="600496" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Using a rapid screening PCR method for frameshift mutations in the HNF1A gene in the screening of 60 MODY probands defined according to strict diagnostic criteria, Frayling et al. (1997) detected mutations in 11 (18%); the insertion mutation accounted for 13% of the MODY cases.</Attribute>
              <Citation>
                <ID Source="PubMed">9439666</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Ellard (2000) stated that the C insertion in the poly(C) tract of exon 4 had been reported in 22 of the 116 families with MODY3 worldwide who were identified by the finding of a mutation in the TCF1 gene. The total number of different mutations described was 65.</Attribute>
              <Citation>
                <ID Source="PubMed">11058894</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Bjorkhaug et al. (2003) found the P291fsinsC mutation in 9 families, 8 of Norwegian origin. Microsatellite analysis data suggested that in 7 of these families the mutant allele had a common origin.</Attribute>
              <Citation>
                <ID Source="PubMed">12574234</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Hepatic Adenoma</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In studies of hepatic adenomas (142330) demonstrating biallelic inactivation of TCF1, Bluteau et al. (2002) observed the pro291fsX316 frameshift mutation (142410.0001) in heterozygous state in the tumor tissue of 2 individuals, one with multiple adenoma and the other with hepatocellular carcinoma (114550).</Attribute>
              <Citation>
                <ID Source="PubMed">12355088</ID>
              </Citation>
              <XRef DB="OMIM" ID="142330" Type="MIM" />
              <XRef DB="OMIM" ID="114550" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Renal Cell Carcinoma</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a 78-year-old man with clear cell renal carcinoma (see 144700), Rebouissou et al. (2005) identified heterozygosity for the 872insC mutation. Mutation screening of a tumor sample detected the germline mutation without mutation/deletion of the second allele. The man was diagnosed with diabetes mellitus in his sixth decade that was controlled by diet and oral hypoglycemic agents. No relatives had a diagnosis of renal carcinoma or diabetes.</Attribute>
              <Citation>
                <ID Source="PubMed">15649945</ID>
              </Citation>
              <XRef DB="OMIM" ID="144700" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Type 1 Diabetes Mellitus 20</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a Japanese subject with type 1 diabetes mellitus (T1D20; 612520) in whom insulin treatment was begun when hyperglycemia and ketonuria were noticed at 15 years of age, Yamada et al. (1997) identified a heterozygous frameshift mutation of codon pro291 resulting from insertion of a C in a poly(C) tract. (They designated this mutation P291fsinsC.) The mutation was predicted to result in a mutant truncated protein of 340 amino acids. The same mutation had been observed in British, German, and Finnish MODY families (Byrne et al., 1996; Yamagata et al., 1996; Kaisaki et al., 1997). Thus, Yamada et al. (1997) concluded that this site in exon 4 of the HNF1A gene appears to be a mutation hotspot.</Attribute>
              <Citation>
                <ID Source="PubMed">9313763</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">8866553</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">8945470</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">9032114</ID>
              </Citation>
              <XRef DB="OMIM" ID="612520" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HNF1A" />
          </GeneList>
          <Name>HNF1A, 1-BP INS, 872C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 872C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="142410.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="included">HEPATIC ADENOMA, SOMATIC</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="36329" SubmissionDate="2020-09-04" DateLastUpdated="2020-09-14" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="142410.0001_MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 3" title="HNF1A, 1-BP INS, 872C_MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 3" />
        <ClinVarAccession Accession="SCV000036329" DateUpdated="2020-09-14" DateCreated="2013-04-04" Type="SCV" Version="5" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2005-03-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Maturity-Onset Diabetes of the Young, Type 3</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a patient from an Edinburgh pedigree with MODY3 (600496), Yamagata et al. (1996) found in exon 4 of the TCF1 gene an insertion of a cytosine at codon 291 (pro), resulting in a frameshift and synthesis of a truncated mutant protein of 315 amino acids. This mutation was present in all affected members and no unaffected members of this family. It was not found on screening 55 healthy nondiabetic white subjects.</Attribute>
              <Citation>
                <ID Source="PubMed">8945470</ID>
              </Citation>
              <XRef DB="OMIM" ID="600496" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Using a rapid screening PCR method for frameshift mutations in the HNF1A gene in the screening of 60 MODY probands defined according to strict diagnostic criteria, Frayling et al. (1997) detected mutations in 11 (18%); the insertion mutation accounted for 13% of the MODY cases.</Attribute>
              <Citation>
                <ID Source="PubMed">9439666</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Ellard (2000) stated that the C insertion in the poly(C) tract of exon 4 had been reported in 22 of the 116 families with MODY3 worldwide who were identified by the finding of a mutation in the TCF1 gene. The total number of different mutations described was 65.</Attribute>
              <Citation>
                <ID Source="PubMed">11058894</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Bjorkhaug et al. (2003) found the P291fsinsC mutation in 9 families, 8 of Norwegian origin. Microsatellite analysis data suggested that in 7 of these families the mutant allele had a common origin.</Attribute>
              <Citation>
                <ID Source="PubMed">12574234</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Hepatic Adenoma</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In studies of hepatic adenomas (142330) demonstrating biallelic inactivation of TCF1, Bluteau et al. (2002) observed the pro291fsX316 frameshift mutation (142410.0001) in heterozygous state in the tumor tissue of 2 individuals, one with multiple adenoma and the other with hepatocellular carcinoma (114550).</Attribute>
              <Citation>
                <ID Source="PubMed">12355088</ID>
              </Citation>
              <XRef DB="OMIM" ID="142330" Type="MIM" />
              <XRef DB="OMIM" ID="114550" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Renal Cell Carcinoma</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a 78-year-old man with clear cell renal carcinoma (see 144700), Rebouissou et al. (2005) identified heterozygosity for the 872insC mutation. Mutation screening of a tumor sample detected the germline mutation without mutation/deletion of the second allele. The man was diagnosed with diabetes mellitus in his sixth decade that was controlled by diet and oral hypoglycemic agents. No relatives had a diagnosis of renal carcinoma or diabetes.</Attribute>
              <Citation>
                <ID Source="PubMed">15649945</ID>
              </Citation>
              <XRef DB="OMIM" ID="144700" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Type 1 Diabetes Mellitus 20</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a Japanese subject with type 1 diabetes mellitus (T1D20; 612520) in whom insulin treatment was begun when hyperglycemia and ketonuria were noticed at 15 years of age, Yamada et al. (1997) identified a heterozygous frameshift mutation of codon pro291 resulting from insertion of a C in a poly(C) tract. (They designated this mutation P291fsinsC.) The mutation was predicted to result in a mutant truncated protein of 340 amino acids. The same mutation had been observed in British, German, and Finnish MODY families (Byrne et al., 1996; Yamagata et al., 1996; Kaisaki et al., 1997). Thus, Yamada et al. (1997) concluded that this site in exon 4 of the HNF1A gene appears to be a mutation hotspot.</Attribute>
              <Citation>
                <ID Source="PubMed">9313763</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">8866553</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">8945470</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">9032114</ID>
              </Citation>
              <XRef DB="OMIM" ID="612520" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HNF1A" />
          </GeneList>
          <Name>HNF1A, 1-BP INS, 872C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 872C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="142410.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 3</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4052794" SubmissionDate="2022-12-05" DateLastUpdated="2022-12-11" DateCreated="2022-01-29">
        <ClinVarSubmissionID localKey="NM_000545.8(HNF1A):c.872dup (p.Gly292fs)|Diabetes mellitus type 1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002070472" DateUpdated="2022-12-11" DateCreated="2022-01-29" Type="SCV" Version="3" SubmitterName="Genetic Services Laboratory, University of Chicago" OrgID="1238" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-01-11">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>DNA sequence analysis of the HNF1A gene demonstrated a single base pair duplication in exon 4, c.872dup. This pathogenic sequence change results in an amino acid frameshift and creates a premature stop codon 24 amino acids downstream of the mutation, p.Gly292Argfs*25. This pathogenic sequence change is predicted to result in an abnormal transcript, which may be degraded, or may lead to the production of a truncated HNF1A protein with potentially abnormal function. This pathogenic sequence change has previously been described in multiple patients and families with HNF1A-related MODY (PMIDs: 8945470, 27913849, PMID: 29666556).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HNF1A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000545.8:c.872dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Diabetes mellitus type 1</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10987855</SubmissionName>
          <SubmissionName>SUB12333713</SubmissionName>
          <SubmissionName>SUB12366149</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5413130" SubmissionDate="2022-12-21" DateLastUpdated="2022-12-24" DateCreated="2022-12-24">
        <ClinVarSubmissionID localKey="vcgs/unit_1/hg38_NM_000545_5_HNF1A_c_872dupC" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002768260" DateUpdated="2022-12-24" DateCreated="2022-12-24" Type="SCV" Version="1" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-02-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">25555642</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">34373539</ID>
          </Citation>
          <Comment>Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with Maturity-onset diabetes of the young type III (MODY type III; MIM#600496). (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). (SP) 0251 - This variant is heterozygous. (I) 0302 - Variant is present in gnomAD (v3) &lt;0.001 for a dominant condition (1 heterozygote, 0 homozygotes). (SP) 0701 - Other NMD-predicted variants comparable to the one identified in this case have very strong previous evidence for pathogenicity (ClinVar). (SP) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. It has been reported in multiple families with MODY (ClinVar, PMID: 34373539, PMID: 25555642). (SP) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HNF1A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_12516</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000545.5:c.872dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="600496" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_38</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5168259" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2022-11-29">
        <ClinVarSubmissionID localKey="a621004|MedGen:C0342276" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002685484" DateUpdated="2024-05-01" DateCreated="2022-11-29" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-12-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">14747304</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23348805</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">8945470</ID>
          </Citation>
          <Comment>The c.872dupC pathogenic mutation, located in coding exon 4 of the HNF1A gene, results from a duplication of C at nucleotide position 872, causing a translational frameshift with a predicted alternate stop codon (p.G292Rfs*25). This mutation (designated as P291fsinsC) was first reported in a MODY family in which the mutation co-segregated with disease (Yamagata K et al. Nature, 1996 Dec;384:455-8). This is the most common HNF1A mutation; it has been reported in multiple maturity-onset diabetes of the young (MODY) families, as well as a de novo occurrence, and as a possible founder mutation in the Norwegian population (Colclough K et al. Hum. Mutat., 2013 May;34:669-85). An in vitro study quantified ectopically expressed mutant transcripts in lymphoblastoid cell lines and reduced mRNA levels to 6% of wild-type (Harries LW et al. Diabetes, 2004 Feb;53:500-4). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HNF1A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000545.5:c.872dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0342276" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="9056166" TraitType="Disease" MappingType="XRef" MappingValue="ORPHA552" MappingRef="Orphanet">
        <MedGen CUI="C0342276" Name="Maturity onset diabetes mellitus in young" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7677315" TraitType="Disease" MappingType="XRef" MappingValue="C0342276" MappingRef="MedGen">
        <MedGen CUI="C0342276" Name="Maturity onset diabetes mellitus in young" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4889842" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0015967" MappingRef="MONDO">
        <MedGen CUI="C3888631" Name="Monogenic diabetes" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="49162" TraitType="Disease" MappingType="Name" MappingValue="HEPATIC ADENOMA, SOMATIC" MappingRef="Alternate">
        <MedGen CUI="C1840646" Name="Hepatic adenomas, familial" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7809795" TraitType="Disease" MappingType="XRef" MappingValue="188400" MappingRef="OMIM">
        <MedGen CUI="C0012236" Name="DiGeorge syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2804983" TraitType="Disease" MappingType="XRef" MappingValue="600496" MappingRef="OMIM">
        <MedGen CUI="C1838100" Name="Maturity-onset diabetes of the young type 3" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6159173" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5413130" TraitType="Disease" MappingType="XRef" MappingValue="600496" MappingRef="OMIM">
        <MedGen CUI="C1838100" Name="Maturity-onset diabetes of the young type 3" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5168259" TraitType="Disease" MappingType="XRef" MappingValue="C0342276" MappingRef="MedGen">
        <MedGen CUI="C0342276" Name="Maturity onset diabetes mellitus in young" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1197291" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2827227" TraitType="Disease" MappingType="Name" MappingValue="TYPE 1 DIABETES MELLITUS 20" MappingRef="Alternate">
        <MedGen CUI="C2675866" Name="Type 1 diabetes mellitus 20" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4052794" TraitType="Disease" MappingType="Name" MappingValue="Diabetes mellitus type 1" MappingRef="Preferred">
        <MedGen CUI="C0011854" Name="Diabetes mellitus type 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1122906" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="36331" TraitType="Disease" MappingType="Name" MappingValue="RENAL CELL CARCINOMA, CLEAR CELL" MappingRef="Alternate">
        <MedGen CUI="C0279702" Name="Clear cell carcinoma of kidney" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="36329" TraitType="Disease" MappingType="Name" MappingValue="MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 3" MappingRef="Preferred">
        <MedGen CUI="C1838100" Name="Maturity-onset diabetes of the young type 3" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5399180" TraitType="Disease" MappingType="XRef" MappingValue="HP:0004904" MappingRef="HP">
        <MedGen CUI="C0342276" Name="Maturity onset diabetes mellitus in young" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="1" DateDeleted="2023-05-04">SCV001656096</Accession>
        <Description>need to update case details</Description>
      </SCV>
      <SCV>
        <Accession Version="4" DateDeleted="2020-09-05">SCV000036332</Accession>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

